Saltar al contenido
Merck

PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.

Molecular cell (2007-03-17)
Kenichi Yamane, Keisuke Tateishi, Robert J Klose, Jia Fang, Laura A Fabrizio, Hediye Erdjument-Bromage, Joyce Taylor-Papadimitriou, Paul Tempst, Yi Zhang
RESUMEN

Posttranslational modification of chromatin by histone methylation has wide-ranging effects on nuclear function, including transcriptional regulation, maintenance of genome integrity, and epigenetic inheritance. The enzymes utilized to place histone methylation marks are well characterized, but the identity of a histone demethylation system remained elusive until recently. The discovery of histone demethylase enzymes capable of directly removing methyl groups from modified lysine residues has demonstrated that histone methylation is a dynamic modification. The most extensive family of histone demethylase enzymes identified so far contains a JmjC domain and catalyzes demethylation through a hydroxylation reaction. Here, we identify PLU-1, a transcriptional repressor implicated in breast cancer, as a histone demethylase enzyme that has the ability to reverse the trimethyl H3K4 modification state. Furthermore, we reveal that PLU-1-mediated H3K4 demethylase activity plays an important role in the proliferative capacity of breast cancer cells through repression of tumor suppressor genes, including BRCA1.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
PLU-1 murine, recombinant, expressed in baculovirus infected Sf9 cells, ≥50% (SDS-PAGE)